Acquisition Opportunity ResoluteAI was acquired by Research Solutions in July 2023, presenting a potential cross-sell path to Research Solutions customers for ResoluteAI’s science-focused research platform and Nebula enterprise search capabilities.

Clinical Data Expansion Recent launch of Clinical Trials Analytics in January 2023 indicates a strong emphasis on integrating clinical trial data with research publications and datasets, offering a sales angle to life sciences organizations seeking end-to-end analytics and regulatory insight.

Workflow Automation Product milestones such as Collections for report generation and next generation API enhancements suggest buyers value collaborative, integrable research workflows and third‑party platform connectivity for streamlined decision-making.

Regulatory & PV Focus Tools for post‑market surveillance and pharmacovigilance launched in 2021 highlight a niche in compliance monitoring and safety analytics, presenting upsell opportunities to medical affairs, pharmacovigilance teams, and regulatory departments.

SMB Enterprise Fit With a lean team size and multi‑sector adoption patterns across R&D, medical affairs, and pharmacovigilance, target mid‑market scientific organizations seeking scalable, enterprise search and analytics without the footprint of larger vendors.